The value of patient reporting to the pharmacovigilance system: a systematic review.

Pedro InácioAfonso CavacoMarja Airaksinen

Published in: British journal of clinical pharmacology (2016)

Patient reporting adds new information, and perspective about ADRs in a way otherwise unavailable. This can contribute to better decision-making processes in regulatory activities. The present review identified gaps in knowledge that should be addressed to improve our understanding of the full potential and drawbacks of patient reporting.

Keyphrases

adverse drug
case report
decision making
emergency department
transcription factor
health information
social media
climate change